NEW YORK, March 03, 2016 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Natural Health Trends Corp. securities (NASDAQ:NHTC) from March 6, 2015 through January 12, 2016, all dates inclusive (the “Class Period”) of the important March 14, 2016 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Natural Health Trends investors under the federal securities laws.
To join the Natural Health Trends class action, go to the firm’s website at http://rosenlegal.com/cases-812.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email [email protected] or [email protected] for more information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE
According to the lawsuit, throughout the Class Period Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) the operations of Natural Health Trends’ Chinese entity is not in compliance with applicable Chinese laws; and (2) as a result, Defendants’ statements about Natural Health Trends’ business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 14, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-812.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 



